These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Interferon-alpha enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells.
    Author: Liedtke C, Gröger N, Manns MP, Trautwein C.
    Journal: J Hepatol; 2006 Feb; 44(2):342-9. PubMed ID: 16225956.
    Abstract:
    BACKGROUND/AIMS: IFNalpha is an approved treatment option for patients chronically infected with the hepatitis B and C viruses. Additionally, there is an indication for tumor therapy. The exact mechanisms underlying the antiviral and antitumor effects of IFNalpha are not completely understood. In this study, we investigated if the pro-apoptotic factor caspase-8 is a target gene of IFNalpha signalling. METHODS: Huh7 hepatoma cells were used for measuring caspase-8 promoter activity in luciferase reporter assays after IFNalpha stimulation. Caspase-8 expression was monitored by RT-PCR, immunoblotting and measurement of enzymatic activity. Functional caspase-8 promoter elements were identified in gelshift assays and by site directed mutagenesis. Caspase-8 was inhibited using siRNA. RESULTS: IFNalpha treatment induced caspase-8 promoter activity and mRNA expression. We identified a unique promoter element mediating the IFNalpha-dependent increase in caspase-8 transcription. Up-regulation of caspase-8 expression by IFNalpha had no impact on the rate of apoptosis per se. However, co-stimulation with IFNalpha doubled TRAIL-mediated apoptosis and enzymatic caspase-8 activity. The synergistic effect of TRAIL and IFNalpha could be blocked by inhibiting caspase-8 expression. CONCLUSIONS: We demonstrate that caspase-8 is a target gene of IFNalpha and provide evidence showing that IFNalpha treatment sensitizes cells for apoptosis via enhanced caspase-8 transcription.
    [Abstract] [Full Text] [Related] [New Search]